![Scientists found the combination of nivolumab and ipilimumab medications led to a reduction in the size of tumours in terminally ill head and neck cancer patients. In some, their cancer vanished altogether, Scientists found the combination of nivolumab and ipilimumab medications led to a reduction in the size of tumours in terminally ill head and neck cancer patients. In some, their cancer vanished altogether,](https://external-preview.redd.it/lqyB3xoEeXm1iOCNhNAsbgDn_z6_oCK1a8BGK5Wsprw.jpg?auto=webp&s=017837d4b58f6f0fafe0d4a1fa017d8325afa42e)
Scientists found the combination of nivolumab and ipilimumab medications led to a reduction in the size of tumours in terminally ill head and neck cancer patients. In some, their cancer vanished altogether,
![BMS gets EC approval for Opdivo, Yervoy combo for treatment of metastatic NSCLC - Pharmaceutical Business review BMS gets EC approval for Opdivo, Yervoy combo for treatment of metastatic NSCLC - Pharmaceutical Business review](https://www.pharmaceutical-business-review.com/wp-content/uploads/2020/02/800px-Bristol_Myers_Squibb_Moreton_Wirral_-_IMG_0369.jpg)
BMS gets EC approval for Opdivo, Yervoy combo for treatment of metastatic NSCLC - Pharmaceutical Business review
![Novartis melanoma combination wins key thumbs-up from cost watchdog NICE after Opdivo shut out | Fierce Pharma Novartis melanoma combination wins key thumbs-up from cost watchdog NICE after Opdivo shut out | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1537277199/Industria_Novartis_wiki_andrew_flickr.jpg/Industria_Novartis_wiki_andrew_flickr.jpg?VersionId=_PpAC1HkEHny74VozD4yVcKMJ3CunVwf)